1. Home
  2. NYT vs RGEN Comparison

NYT vs RGEN Comparison

Compare NYT & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NYT
  • RGEN
  • Stock Information
  • Founded
  • NYT 1851
  • RGEN 1981
  • Country
  • NYT United States
  • RGEN United States
  • Employees
  • NYT N/A
  • RGEN N/A
  • Industry
  • NYT Newspapers/Magazines
  • RGEN Medical/Dental Instruments
  • Sector
  • NYT Consumer Discretionary
  • RGEN Health Care
  • Exchange
  • NYT Nasdaq
  • RGEN Nasdaq
  • Market Cap
  • NYT 9.1B
  • RGEN 8.2B
  • IPO Year
  • NYT N/A
  • RGEN N/A
  • Fundamental
  • Price
  • NYT $53.44
  • RGEN $141.78
  • Analyst Decision
  • NYT Buy
  • RGEN Buy
  • Analyst Count
  • NYT 5
  • RGEN 10
  • Target Price
  • NYT $50.60
  • RGEN $188.38
  • AVG Volume (30 Days)
  • NYT 672.9K
  • RGEN 926.2K
  • Earning Date
  • NYT 08-07-2024
  • RGEN 10-29-2024
  • Dividend Yield
  • NYT 0.99%
  • RGEN N/A
  • EPS Growth
  • NYT 52.50
  • RGEN N/A
  • EPS
  • NYT 1.62
  • RGEN N/A
  • Revenue
  • NYT $2,467,072,000.00
  • RGEN $602,354,000.00
  • Revenue This Year
  • NYT $8.54
  • RGEN $0.08
  • Revenue Next Year
  • NYT $6.68
  • RGEN $12.97
  • P/E Ratio
  • NYT $32.35
  • RGEN N/A
  • Revenue Growth
  • NYT 5.50
  • RGEN N/A
  • 52 Week Low
  • NYT $39.73
  • RGEN $110.45
  • 52 Week High
  • NYT $56.49
  • RGEN $211.13
  • Technical
  • Relative Strength Index (RSI)
  • NYT 45.69
  • RGEN 43.50
  • Support Level
  • NYT $52.23
  • RGEN $138.80
  • Resistance Level
  • NYT $54.90
  • RGEN $150.72
  • Average True Range (ATR)
  • NYT 0.79
  • RGEN 4.98
  • MACD
  • NYT -0.26
  • RGEN -0.92
  • Stochastic Oscillator
  • NYT 26.41
  • RGEN 24.50

About NYT New York Times Company (The)

New York Times Co is an American media company known for publishing its flagship newspaper, The New York Times. The company also operates the International New York Times newspaper, as well as digital properties such as NYTimes and various smartphone applications. The company has two segments New York Times Group and The Athletic. The company generates the majority of its revenue from the NYTG segment. The NYTG and The Athletic segments derive revenue from subscriptions, Advertising, and others, where the major source of revenue for both segments is subscription.

About RGEN Repligen Corporation

Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S., Europe, and Asia, as well as through strategic partners in select markets. The majority of the company's revenue is generated in North America.

Share on Social Networks: